NYSE - Delayed Quote USD

Alcon Inc. (ALC)

88.83 -0.23 (-0.26%)
At close: May 17 at 4:00 PM EDT
88.70 -0.13 (-0.15%)
After hours: May 17 at 4:50 PM EDT
Loading Chart for ALC
DELL
  • Previous Close 89.06
  • Open 88.22
  • Bid 88.92 x 1100
  • Ask 91.90 x 1000
  • Day's Range 87.86 - 89.07
  • 52 Week Range 69.44 - 90.00
  • Volume 624,371
  • Avg. Volume 938,279
  • Market Cap (intraday) 43.815B
  • Beta (5Y Monthly) 0.68
  • PE Ratio (TTM) 42.10
  • EPS (TTM) 2.11
  • Earnings Date May 13, 2024
  • Forward Dividend & Yield 0.27 (0.30%)
  • Ex-Dividend Date May 14, 2024
  • 1y Target Est 94.34

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

www.alcon.com

25,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALC

Performance Overview: ALC

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALC
14.08%
MSCI WORLD
9.57%

1-Year Return

ALC
10.60%
MSCI WORLD
23.91%

3-Year Return

ALC
31.18%
MSCI WORLD
0.00%

5-Year Return

ALC
46.87%
MSCI WORLD
63.33%

Compare To: ALC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALC

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    43.59B

  • Enterprise Value

    47.53B

  • Trailing P/E

    42.10

  • Forward P/E

    28.33

  • PEG Ratio (5yr expected)

    4.98

  • Price/Sales (ttm)

    4.61

  • Price/Book (mrq)

    2.10

  • Enterprise Value/Revenue

    4.97

  • Enterprise Value/EBITDA

    20.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.96%

  • Return on Assets (ttm)

    2.38%

  • Return on Equity (ttm)

    5.15%

  • Revenue (ttm)

    9.56B

  • Net Income Avi to Common (ttm)

    1.05B

  • Diluted EPS (ttm)

    2.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.15B

  • Total Debt/Equity (mrq)

    24.44%

  • Levered Free Cash Flow (ttm)

    620.75M

Research Analysis: ALC

Company Insights: ALC

Research Reports: ALC

People Also Watch